Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cepheid (NASDAQ:CPHD)

U.S. Markets are not yet open, but CPHD is being traded in the pre-market session. Pre-Market quote »
49.33
Delayed Data
As of Aug 27
 +0.71 / +1.47%
Today’s Change
38.97
Today|||52-Week Range
63.69
-8.88%
Year-to-Date
No recent news for Cepheid.

Today’s Trading

Previous close48.62
Today’s open48.91
Day’s range48.08 - 49.43
Volume586,188
Average volume (3 months)709,460
Market cap$3.6B
Dividend yield--
Data as of 08/27/2015

Growth & Valuation

Earnings growth (last year)-166.67%
Earnings growth (this year)+31.61%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+16.80%
P/E ratioNM
Price/Sales8.08
Price/Book9.87

Competitors

 Today’s
change
Today’s
% change
BIOBio Rad Laboratories...+3.54+2.57%
BRKRBruker Corp+0.21+1.13%
FEICFEI Co+1.11+1.50%
PKIPerkinElmer Inc+1.40+2.91%
Data as of 08/27/2015

Financials

Next reporting dateOctober 15, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$469.7M
Annual profit (last year)-$50.1M
Net profit margin-10.68%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John L. Bishop
Chief Operating Officer &
Executive Vice President
Warren C. Kocmond
Corporate headquarters
Sunnyvale, California

Forecasts

Partner Offers